| Authors: |
Pierson JB; Health and Environmental Sciences Institute, Washington, DC, USA., Berridge B; B2 Pathology Solutions LLC, Cary, NC, USA., Blinova K; Food and Drug Administration, Silver Spring, MD, USA., Brooks MB; Comparative Coagulation Section, Department of Population Medicine and Diagnostic Sciences, Cornell University, Ithaca, NY, USA., Eldridge S; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., O'Brien CE; Health and Environmental Sciences Institute, Washington, DC, USA. Electronic address: cobrien@hesiglobal.org., Pugsley MK; Toxicology & Safety Pharmacology, Cytokinetics, South San Francisco, CA, USA., Schultze AE; Pathology, Lilly Research Laboratories, Indianapolis, IN, USA., Smith G; Clyde Biosciences Ltd, Newhouse, UK; University of Glasgow, Scotland, UK., Stockbridge N; Food and Drug Administration, Silver Spring, MD, USA., Valentin JP; UCB Biopharma SRL, Development Science, Non-Clinical Safety Evaluation, Braine l'Alleud, Belgium., Vicente J; Food and Drug Administration, Silver Spring, MD, USA. |
